13-Valent Pneumococcal Polysaccharide Conjugate Vaccine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Overall Market Size
2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size: 2022 VS 2032
2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, Prospects & Forecasts: 2018-2032
2.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales: 2018-2032
3 Company Landscape
3.1 Top 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Players in Global Market
3.2 Top Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Companies Ranked by Revenue
3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Companies
3.4 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Companies
3.5 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Type
3.8 Tier 1, Tier 2 and Tier 3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Players in Global Market
3.8.1 List of Global Tier 1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Companies
3.8.2 List of Global Tier 2 and Tier 3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Markets, 2022 & 2032
4.1.2 Serotype 6B
4.1.3 7F Serotype
4.1.4 Serotype 9V
4.1.5 14 Serotype
4.1.6 Serotype 18C
4.1.7 Serotype 19A
4.1.8 19F Serotype
4.1.9 23F Serotype
4.1.10 24F Serotype
4.1.11 Other
4.2 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue & Forecasts
4.2.1 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2018-2023
4.2.2 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2024-2032
4.2.3 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2018-2032
4.3 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales & Forecasts
4.3.1 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2018-2023
4.3.2 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2024-2032
4.3.3 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2018-2032
4.4 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2022 & 2032
5.1.2 Infants from 6 Weeks to 15 Months Old
5.1.3 Children Aged 15 Months to 5 Years
5.2 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue & Forecasts
5.2.1 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2018-2023
5.2.2 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2024-2032
5.2.3 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2018-2032
5.3 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales & Forecasts
5.3.1 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2018-2023
5.3.2 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2024-2032
5.3.3 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2018-2032
5.4 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2022 & 2032
6.2 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue & Forecasts
6.2.1 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2018-2023
6.2.2 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2024-2032
6.2.3 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2018-2032
6.3 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales & Forecasts
6.3.1 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2018-2023
6.3.2 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2024-2032
6.3.3 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2018-2032
6.4.2 By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2018-2032
6.4.3 US 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.4.4 Canada 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.4.5 Mexico 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2018-2032
6.5.2 By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2018-2032
6.5.3 Germany 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.5.4 France 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.5.5 U.K. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.5.6 Italy 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.5.7 Russia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.5.8 Nordic Countries 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.5.9 Benelux 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2018-2032
6.6.2 By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2018-2032
6.6.3 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.6.4 Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.6.5 South Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.6.6 Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.6.7 India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2018-2032
6.7.2 By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2018-2032
6.7.3 Brazil 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.7.4 Argentina 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2018-2032
6.8.3 Turkey 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.8.4 Israel 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.8.5 Saudi Arabia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
6.8.6 UAE 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Major Product Offerings
7.1.4 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Minhai Bio
7.2.1 Minhai Bio Company Summary
7.2.2 Minhai Bio Business Overview
7.2.3 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Major Product Offerings
7.2.4 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Revenue in Global (2018-2023)
7.2.5 Minhai Bio Key News & Latest Developments
7.3 Kexing Bio
7.3.1 Kexing Bio Company Summary
7.3.2 Kexing Bio Business Overview
7.3.3 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Major Product Offerings
7.3.4 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Revenue in Global (2018-2023)
7.3.5 Kexing Bio Key News & Latest Developments
7.4 Cansino Bio
7.4.1 Cansino Bio Company Summary
7.4.2 Cansino Bio Business Overview
7.4.3 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Major Product Offerings
7.4.4 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Revenue in Global (2018-2023)
7.4.5 Cansino Bio Key News & Latest Developments
7.5 Lanzhou Biological Preparations Institute
7.5.1 Lanzhou Biological Preparations Institute Company Summary
7.5.2 Lanzhou Biological Preparations Institute Business Overview
7.5.3 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Major Product Offerings
7.5.4 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Revenue in Global (2018-2023)
7.5.5 Lanzhou Biological Preparations Institute Key News & Latest Developments
8 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Capacity, Analysis
8.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Capacity, 2018-2032
8.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Capacity of Key Manufacturers in Global Market
8.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Supply Chain Analysis
10.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Value Chain
10.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Upstream Market
10.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) in Global Market
Table 2. Top 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Players in Global Market, Ranking by Revenue (2022)
Table 3. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Share by Companies, 2018-2023
Table 5. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Companies, (K Units), 2018-2023
Table 6. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Type
Table 9. List of Global Tier 1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), 2018-2023
Table 15. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), 2024-2032
Table 16. By Application ? Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), 2018-2023
Table 20. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), 2024-2032
Table 21. By Region ? Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), 2018-2023
Table 25. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), 2024-2032
Table 26. By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2018-2023
Table 29. By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2024-2032
Table 30. By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2018-2023
Table 33. By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2024-2032
Table 34. By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2018-2023
Table 37. By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2024-2032
Table 38. By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2018-2023
Table 41. By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2024-2032
Table 42. By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2024-2032
Table 46. Pfizer Company Summary
Table 47. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offerings
Table 48. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Minhai Bio Company Summary
Table 51. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offerings
Table 52. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Minhai Bio Key News & Latest Developments
Table 54. Kexing Bio Company Summary
Table 55. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offerings
Table 56. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Kexing Bio Key News & Latest Developments
Table 58. Cansino Bio Company Summary
Table 59. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offerings
Table 60. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Cansino Bio Key News & Latest Developments
Table 62. Lanzhou Biological Preparations Institute Company Summary
Table 63. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offerings
Table 64. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Lanzhou Biological Preparations Institute Key News & Latest Developments
Table 66. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 67. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Capacity Market Share of Key Manufacturers, 2021-2023
Table 68. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Region, 2018-2023 (K Units)
Table 69. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Region, 2024-2032 (K Units)
Table 70. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Opportunities & Trends in Global Market
Table 71. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Drivers in Global Market
Table 72. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Restraints in Global Market
Table 73. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Raw Materials
Table 74. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Raw Materials Suppliers in Global Market
Table 75. Typical 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Downstream
Table 76. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Downstream Clients in Global Market
Table 77. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Type in 2022
Figure 2. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Application in 2022
Figure 3. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2018-2032 (US$, Mn)
Figure 7. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales in Global Market: 2018-2032 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue in 2022
Figure 9. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2018-2032
Figure 11. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2018-2032
Figure 12. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (US$/Unit), 2018-2032
Figure 13. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2018-2032
Figure 15. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2018-2032
Figure 16. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (US$/Unit), 2018-2032
Figure 17. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2018-2032
Figure 20. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2018-2032
Figure 21. By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2018-2032
Figure 22. By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2018-2032
Figure 23. US 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 24. Canada 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2018-2032
Figure 27. By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2018-2032
Figure 28. Germany 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 29. France 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 31. Italy 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 32. Russia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2018-2032
Figure 36. By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2018-2032
Figure 37. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 38. Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 41. India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2018-2032
Figure 43. By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2018-2032
Figure 44. Brazil 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2018-2032
Figure 48. Turkey 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 49. Israel 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 51. UAE 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2018-2032
Figure 52. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Capacity (K Units), 2018-2032
Figure 53. The Percentage of Production 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Region, 2022 VS 2032
Figure 54. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Value Chain
Figure 55. Marketing Channels
Industry Market Size
